Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GENUFLEX: Xeomin for Gait in Hemiparesis
NCT03119948Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2014
- Primary completion
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in hemiparesis, sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
hemiparesis
Beyond the preview
Go deeper on NCT03119948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03119948.